Skip to main content

Table 3 Unadjusted survival proportions in overall microscopically confirmed stages I–II and III–IV pancreatic cancer patients

From: Stratified survival of resected and overall pancreatic cancer patients in Europe and the USA in the early twenty-first century: a large, international population-based study

Time USA The Netherlands Belgium Norway Slovenia
Stages I–II Stages III–IV Stages I–II Stages III–IV Stages I–II Stages III–IV Stages I–II Stages III–IV Stages I–II Stages III–IV
OS (95% CI)a OS (95% CI) OS (95% CI) OS (95% CI) OS (95% CI) OS (95% CI) OS (95% CI) OS (95% CI) OS (95% CI) OS (95% CI)
1 month
  ≤ 60 years 96 (95–96) 77 (76–78) 98 (97–99) 87 (86–89) 98 (97–99) 93 (91–95) 99 (96–100) 92 (90–94) 98 (93–99) 87 (82–90)
 60–69 years 93 (92–93) 72 (71–72) 96 (95–97) 83 (82–84) 97 (96–98) 89 (87–91) 97 (94–98) 87 (85–89) 97 (92–99) 82 (77–86)
  ≥ 70 years 84 (84–85) 60 (59–61) 92 (90–93) 74 (72–75) 93 (92–94) 81 (80–83) 96 (94–98) 80 (78–82) 94 (90–97) 67 (63–72)
3 months
  ≤ 60 years 90 (90–91) 59 (58–60) 93 (91–94) 61 (59–63) 95 (93–96) 78 (75–80) 96 (93–98) 67 (63–70) 95 (90–98) 61 (55–67)
 60–69 years 86 (85–87) 53 (53–54) 89 (87–91) 55 (53–57) 92 (91–94) 69 (67–71) 91 (88–94) 59 (56–62) 93 (88–96) 54 (48–59)
  ≥ 70 years 71 (71–72) 40 (39–40) 79 (77–81) 42 (41–44) 83 (81–84) 55 (53–56) 85 (82–88) 44 (42–47) 81 (75–86) 39 (35–44)
6 months
  ≤ 60 years 81 (80–82) 41 (40–42) 83 (81–86) 36 (34–37) 90 (87–92) 59 (56–62) 88 (82–91) 43 (39–46) 92 (85–95) 44 (38–49)
 60–69 years 74 (73–75) 35 (35–36) 79 (77–81) 32 (31–34) 86 (83–88) 50 (48–53) 79 (74–83) 37 (34–40) 82 (74–87) 40 (34–45)
  ≥ 70 years 57 (56–57) 24 (24–25) 63 (61–66) 22 (21–23) 67 (65–69) 34 (32–35) 67 (63–71) 22 (20–24) 70 (63–76) 19 (16–23)
12 months
  ≤ 60 years 60 (58–61) 20 (20–21) 62 (59–65) 13 (12–15) 72 (69–76) 31 (28–34) 65 (58–71) 20 (17–23) 65 (56–72) 17 (13–22)
 60–69 years 54 (52–55) 17 (17–18) 57 (54–59) 12 (11–13) 65 (62–68) 24 (22–26) 55 (49–60) 13 (11–15) 59 (50–66) 19 (15–24)
  ≥ 70 years 36 (35–36) 10 (10–11) 40 (38–42) 7 (7–8) 43 (40–45) 14 (13–15) 42 (37–46) 7 (6–9) 49 (42–56) 7 (5–10)
24 months
  ≤ 60 years 36 (34–37) 7 (6–7) 31 (28–34) 4 (4–5) 47 (43–51) 10 (9–12) 39 (32–46) 7 (5–9) 35 (27–43) 6 (3–9)
 60–69 years 30 (29–31) 5 (5–6) 30 (27–33) 3 (2–3) 38 (35–41) 6 (4–7) 30 (25–35) 3 (2–4) 24 (18–31) 4 (2–6)
  ≥ 70 years 18 (17–19) 3 (3–3) 20 (18–22) 2 (1–2) 21 (19–22) 3 (3–4) 19 (16–23) 2 (1–3) 25 (19–31) 2 (1–4)
36 months
  ≤ 60 years 26 (24–27) 3 (3–4) 21 (18–24) 2 (2–3) 34 (30–37) 5 (4–7) 25 (19–32) 4 (2–6) 23 (16–30) 2 (1–4)
 60–69 years 20 (19–21) 2 (2–3) 19 (17–22) 1 (1–2) 25 (22–28) 2 (1–3) 19 (14–24) 1 (< 1–2) 14 (9–20) 2 (1–3)
  ≥ 70 years 12 (11–12) 1 (1–2) 14 (12–16) 1 (< 1–1) 13 (11–14) 1 (1–2) 13 (10–17) 1 (< 1–1) 14 (9–19) 1 (< 1–2)
60 months
  ≤ 60 years 19 (18–20) 2 (1–2) 14 (12–17) 1 (1–1) 23 (19–26) 2 (1–3) 16 (11–22) 1 (< 1–2) 15 (9–23) 2 (1–4)
 60–69 years 13 (12–14) 1 (1–1) 12 (10–14) < 1 (< 1–1) 16 (14–19) 1 (< 1–1) 13 (9–18) < 1 (< 1–1) 8 (4–14) 1 (< 1–3)
  ≥ 70 years 7 (7–8) 1 (< 1–1) 7 (6–9) < 1 (< 1–1) 7 (6–8) 1 (< 1–1) 8 (5–11) < 1 (< 1–1) 8 (5–13) < 1 (< 1–1)
  1. OS overall survival, CI confidence interval
  2. aData are shown as survival proportion (95% confidence interval) [%]